Proshares Ultrashort Nasdaq Biotechnology ETF Forecast

Sell candidate since Jun 11, 2026 Loss -6.75%

The ProShares UltraShort Nasdaq ETF price fell by -3.68% on the last day (Monday, 22nd Jun 2026) from $16.33 to $15.73. It has now fallen 3 days in a row. During the last trading day the ETF fluctuated 2.33% from a day low at $15.64 to a day high of $16.00. The price has fallen in 7 of the last 10 days and is down by -9.48% for this period. Volume fell on the last day along with the ETF, which is actually a good sign as volume should follow the ETF. On the last day, the trading volume fell by -5 thousand shares and in total, 3 thousand shares were bought and sold for approximately $54.79 thousand.

The ETF lies in the middle of a wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the ETF is expected to fall -6.36% during the next 3 months and, with a 90% probability hold a price between $14.12 and $16.89 at the end of this 3-month period.

BIS Signals & Forecast

There are few to no technical positive signals at the moment. The ProShares UltraShort Nasdaq ETF holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the ETF. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $16.48 and $17.09. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Tuesday, June 02, 2026, and so far it has fallen -14.06%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell along with the price during the last trading day which is technical positive. One should, however, note that this ETF may have low liquidity in periods, which increases the general risk. The very low volume increases the risk and reduces the other technical signals issued.

Support, Risk & Stop-loss for ProShares UltraShort Nasdaq ETF

There is no support from accumulated volume below today's level and given the right condition the ETF may perform very badly in the next couple of days.

This ETF has average movements during the day, but be aware of low or falling volume as this increases the risk. During the last day, the ETF moved $0.365 between high and low, or 2.33%. For the last week the ETF has had daily average volatility of 2.93%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (BIS) For The Upcoming Trading Day Of Tuesday 23rd

For the upcoming trading day on Tuesday, 23rd we expect ProShares UltraShort Nasdaq Biotechnology to open at $15.79, and during the day (based on 14 day Average True Range), to move between $15.40 and $16.05, which gives a possible trading interval of +/-$0.644 (+/-4.18%) up or down from last closing price. If ProShares UltraShort Nasdaq Biotechnology takes out the full calculated possible swing range there will be an estimated 4.18% move between the lowest and the highest trading price during the day.

With no support below and resistance from accumulated volume @ $16.87, some $1.15 (7.29%) from the current price of $15.73, our system finds the risk reward not very attractive.

Is ProShares UltraShort Nasdaq Biotechnology ETF A Buy?

ProShares UltraShort Nasdaq holds several negative signals and is within a wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this ETF. We have upgraded our analysis conclusion for this ETF since the last evaluation from a Strong Sell to a Sell candidate.

Current score: -4.327 Sell Candidate Upgraded

Predicted Fair Opening Price

Predicted fair opening price on June 23, 2026 - $15.79 ( 0.390%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk